AllianceBernstein Files 8-K on Equity Sales
Ticker: AB · Form: 8-K · Filed: Dec 19, 2024 · CIK: 825313
| Field | Detail |
|---|---|
| Company | Alliancebernstein Holding L.P. (AB) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $35.59 |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-securities, filing, disclosure
TL;DR
AB filed an 8-K for unregistered equity sales - details to follow.
AI Summary
On December 19, 2024, AllianceBernstein Holding L.P. filed an 8-K report. The filing primarily concerns unregistered sales of equity securities and includes financial statements and exhibits. No specific dollar amounts or dates for these sales were detailed in the provided excerpt.
Why It Matters
This filing indicates potential changes in the company's equity structure, which could impact ownership and future financial reporting.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not immediately indicate significant financial distress or operational changes.
Key Players & Entities
- ALLIANCEBERNSTEIN HOLDING L.P. (company) — Registrant
- December 19, 2024 (date) — Date of Report
FAQ
What type of equity securities were sold?
The provided excerpt does not specify the type of equity securities involved in the unregistered sales.
Were these sales material to AllianceBernstein's financial position?
The excerpt does not provide information to assess the materiality of these unregistered sales.
What is the purpose of filing an 8-K for unregistered sales of equity securities?
An 8-K is filed to report significant events that shareholders should be aware of, including unregistered sales of equity securities, as required by the SEC.
Does the filing indicate any new financing or capital raising activities?
The filing mentions 'Unregistered Sales of Equity Securities' which can be a form of capital raising, but specific details are not in the excerpt.
When was the report filed?
The report was filed on December 19, 2024.
Filing Stats: 905 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2024-12-19 16:07:08
Key Financial Figures
- $35.59 — for a cash purchase price per share of $35.59. AB intends to use the proceeds from th
Filing Documents
- ab-20241219.htm (8-K) — 32KB
- exhibit101exchangeagreement.htm (EX-10.1) — 60KB
- exhibit102purchaseagreement.htm (EX-10.2) — 48KB
- 0000825313-24-000087.txt ( ) — 280KB
- ab-20241219.xsd (EX-101.SCH) — 2KB
- ab-20241219_lab.xml (EX-101.LAB) — 21KB
- ab-20241219_pre.xml (EX-101.PRE) — 12KB
- ab-20241219_htm.xml (XML) — 3KB
02. Unregistered sale of equity securities
Item 3.02. Unregistered sale of equity securities. On December 19, 2024, AllianceBernstein L.P. ("AB") entered into a master exchange agreement (the "Exchange Agreement") providing for the issuance by AB of up to 10,000,000 units representing assignments of beneficial ownership of limited partnership interests in AB ("AB Units") to Equitable Holdings, Inc. ("EQH") and any of its wholly-owned subsidiaries in exchange for an equal number of units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units") owned by EQH and such subsidiary, with such exchanges to occur from time to time over the next two years. Each AB Holding Unit so exchanged for will be retired following such exchange. At the time the Exchange Agreement was entered into, AB and EQH exchanged 5,211,194 AB Units for AB Holding Units (thereby reducing the 10,000,000 AB Units available for future exchange), and the acquired AB Holding Units were retired. The issuance of the AB Units was exempt from the registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2) thereof because such issuance did not involve a public offering. In addition to the Exchange Agreement, on December 19, 2024, AB entered into a purchase agreement (the "Purchase Agreement") providing for, and consummated, the sale by AB of 4,215,140 AB Units to EQH for a cash purchase price per share of $35.59. AB intends to use the proceeds from the sale for debt repayment, to extend borrowing capacity in anticipation of funding recently announced investment initiatives in insurance asset management. The issuance of the AB Units was exempt from the registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2) thereof because such issuance did not involve a public offering.
Forward-looking Statements
Forward-looking Statements The Company cautions that all statements, other than statements of historical facts, contained in this Current Report on Form 8-K, or furnished herewith, are forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry's actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements. The use of words such as "may," "might," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "project," "intend," "future," "potential," or "continue," and other similar expressions are intended to identify forward looking statements. However, the absence of these words does not mean that statements are not forward-looking. All forward-looking statements are based on current estimates, assumptions and expectations by our management that, although we believe to be reasonable, are inherently uncertain. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and are subject to risks and uncertainties and other factors beyond our control that may cause actual results to differ materially from those expressed in any forward-looking statement. Any forward-looking statement speaks only as of the date on which it was made. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. 10.1 Exchange Agreement. 10.2 Purchase Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ALLIANCEBERNSTEIN HOLDING L.P. Dated: December 19, 2024 By: /s/ Mark Manley Mark Manley Corporate Secretary